3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Body Dysmorphic Disorders

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Body Dysmorphic Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Booij, J; Denys, D; Figee, M; Planting, RS; Vulink, NC	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Body Dysmorphic Disorders

Article	Year
Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:2 Topics: Adult; Benzamides; Body Dysmorphic Disorders; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Female; Humans; Image Processing, Computer-Assisted; Male; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Young Adult	2016

Article

Year

Reduced striatal dopamine D2/3 receptor availability in Body Dysmorphic Disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:2

Topics: Adult; Benzamides; Body Dysmorphic Disorders; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Female; Humans; Image Processing, Computer-Assisted; Male; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Young Adult

2016